Pathways To Treatment In Blinding Genetic Retinal Eye Diseases
Funder
National Health and Medical Research Council
Funding Amount
$556,956.00
Summary
Blinding eye diseases with genetic contributing factors affecting the retina or light-sensing part of the eye, damage the vision of millions of people worldwide. The vision impairment is irreversible, untreatable, and worsens with age. In this project, we will use technological breakthroughs in genome correction and sequencing, in combination with stem cell and mouse model applications, to develop pathways to treatment of these currently incurable diseases.